NSE IPO 2026: KIRA Score, valuation & risk analysis
A source-led analysis of the National Stock Exchange of India IPO: issue structure, price band, FY26 earnings, BSE comparison, regulatory overhang, concentration risk and the KIRA Score framework.
What investors are actually being offered
The issue is entirely secondary: 12,64,36,650 shares, approximately 5.1% of equity, are offered for sale. NSE receives no fresh capital. At the upper band of ₹1,785, the report computes an equity value of roughly ₹4.42 lakh crore and a FY26 P/E of about 42.89x.
100% offer for sale
No fresh issue and no proceeds to NSE. The report treats this as an AMBER issue-structure flag rather than an operating weakness.
Dominant market infrastructure
The report cites 93% of India's cash equity market, approximately 100% of equity futures and currency derivatives, and 73% of equity options on premium value.
Debt-free
Net worth is reported at ₹32,113.54 crore with 33% return on equity. Financial Strength is the highest-scoring KIRA component at 86.
| IPO detail | KIRA report value | Research read |
|---|---|---|
| Issue size | ₹22,562 Cr | Large 100% OFS; NSE receives no proceeds |
| Shares offered | 12,64,36,650 (~5.1%) | Secondary liquidity event |
| Price band | ₹1,700–₹1,785 | FY26 P/E 40.85x–42.89x^ |
| Issue dates | 17–21 Sep 2026 | Status at report publication: open |
| Listing | BSE · 24 Sep 2026 | NSE cannot list on itself |
| Anchor book | ₹6,746.2 Cr · 150+ investors | Strong institutional validation in KIRA's framework |
Why NSE scores 72.3/100
NSE's score is driven by exceptional business quality and financial strength, offset by a weaker FY26 earnings trajectory, options concentration, regulatory dependence and competitive erosion in the segment that matters most.
The unusual part of the score
The report places NSE below BSE's 75.2 despite NSE being the larger, more dominant and debt-free exchange. KIRA's explanation is mechanical rather than promotional: Fundamentals carries 25% of the model, and NSE's FY26 profit fell 15.47% while BSE's rose about 88%. NSE wins decisively on Business Quality and Financial Strength; it loses the heaviest weighted component for the year being scored.
The regulatory overhang is gone. The earnings question replaced it.
SEBI issued the No-Objection Certificate on 30 January 2026. The co-location and dark-fibre matters were settled for a cumulative ₹1,491.21 crore without admission of guilt, and the Supreme Court disposed of SEBI's appeals on 3 September 2026. The KIRA report therefore treats the decade-long listing block as resolved.
What improved
NOC granted, settlement paid, Supreme Court appeals disposed, debt remains nil, institutional demand is strong, and Q1 FY27 PAT grew 6.7% year on year.
What deteriorated
FY26 revenue from operations fell 3.15%, operating EBITDA fell 12.25%, reported PAT fell 15.47%, ROE fell from 45% to 33%, and EBITDA margin fell from 74% to 67%.
Same sector. Same year. Opposite earnings direction.
KIRA's report frames valuation through the divergence between NSE and listed peer BSE rather than through a single multiple in isolation.
| Metric | NSE | BSE | KIRA read |
|---|---|---|---|
| FY26 revenue from operations | ₹16,601.31 Cr | ₹4,833.95 Cr | NSE is 3.43x larger^ |
| FY26 reported PAT | ₹10,302.06 Cr | ₹2,487 Cr | NSE profit is 4.14x BSE^ |
| FY26 PAT growth | −15.47%^ | ~+88% | Opposite directions |
| Market capitalisation | ₹4,41,787 Cr^ | ₹1,32,154 Cr | 3.34x^ |
| P/E | 42.89x^ | ~49.5x–54.28x | NSE discount 13–21%^ |
| Q1 FY27 PAT growth | +6.7% | ~+65% | Divergence persisted |
Why the discount is not automatically “cheap”
The report argues that NSE's lower multiple is attached to a slower earnings trajectory. The discount is real, but so is the divergence. KIRA explicitly declines to forecast whether FY26 was the trough of a regulatory shock or the start of a structurally smaller options pool.
60.2% of operating revenue comes from equity options
This is the single most important concentration finding in the report. Transaction charges are 78.7% of operating revenue, and equity options alone contribute ₹9,996 crore — 60.2% of operating revenue and 76.6% of transaction charges.
₹16,601 Cr
Base for the concentration analysis.
78.7%
₹13,057 crore of operating revenue.
60.2%
The exact product area affected by tighter derivatives regulation.
Why this matters for the NSE IPO
The report links the earnings decline to derivatives-policy changes: fewer weekly expiries, larger contract sizes, higher margins, expiry-day changes and higher securities transaction tax. Unique individual derivatives traders also fell materially. KIRA treats the policy path for weekly expiries as the single largest reassessment trigger.
IPO price below the private-market mark — but the gap needs context
At ₹1,785, the report computes a 13.31% discount to an unlisted-market quote of ₹2,059 on 17 September. It separately records a grey-market premium range of ₹125–₹285, but marks both unlisted and GMP figures as unofficial, platform-dependent and not dealing quotes.
₹1,785
42.89x^ FY26 earnings.
₹2,059
17 Sep quote in the report; unofficial and platform-dependent.
₹125–₹285
Unofficial range recorded in the report; not a dealing quote or guaranteed listing outcome.
What the KIRA report says to monitor
Single-product, single-regulator dependence
60.2%^ of operating revenue comes from equity options, the product area that has faced repeated regulatory tightening.
Earnings trajectory
FY26 PAT −15.47%^, EBITDA −12.25%^ and ROE 45%→33%. Normalised PBT still fell 5%.
Revenue concentration
Transaction charges are 78.7%^ of operating revenue; non-transaction revenue is improving but still only 21.3%^.
Competitive erosion in options
BSE options notional share rose from 6% in FY21 to more than 42% in FY26; premium share reached 28%.
100% OFS
NSE receives none of the ₹22,562 crore issue proceeds.
Valuation
42.89x^ FY26 earnings and 13.76x^ book; the discount to BSE is attached to declining earnings.
NSE IPO? Check the KIRA Score.
Use KIRA's research framework to separate business quality, financial strength, valuation and risk instead of relying on one headline number.
Direct answers to common NSE IPO questions
What is the KIRA Score for the NSE IPO?
What is the NSE IPO price band?
How large is the NSE IPO?
Is the NSE IPO a fresh issue?
Where is NSE expected to list?
What is KIRA's main concern?
Is NSE IPO GMP official?
Last updated: 17 Sep 2026 · Research Before Returns.